Principal Investigator:
Dott.ssa Rita Murri, Dott. Nikola Dino Capocchiano, Ing. Carlotta Masciocchi, Dott. Alessandro Cozzi Lepri
Target:
Retrospective evaluation of the therapeutic efficacy of non-viral therapy in COVID-19 pneumonia by emulation trial:
- to explore the difference in clinical efficacy of immunomodulators (tocilizumab and sarilumab)nvs LMWH vs concurrent immunomodulators/LMWH
- to explore the difference in clinical efficacy in patients treated with LMWH at different dosages (prophylactic, higher prophylactic, therapeutic) compared with no heparin
- to explore the difference in clinical efficacy of immunomodulators and/or LMWH according to the time of onset of COVID-related symptoms